Researcher Profile

Michael S. Gordon, D.P.A.

Dr. Gordon, Research Scientist at Friends Research Institute (FRI), has been conducting substance abuse treatment research with criminal justice populations for the past 11 years. Dr. Gordon’s research is focused on developing, implementing, and evaluating innovative drug abuse treatment interventions for prisoners with heroin addiction histories. Recently, Dr. Gordon, an early stage investigator, was awarded his first R01. He is the Principal Investigator on a 5-year NIDA funded study examining Seek, Test, and Treat: Addressing HIV in the Criminal Justice System. In addition, he is Co-Investigator on three National Institute on Drug Abuse-funded studies, Buprenorphine for Prisoners, Prevention of Relapse to Opioid Addiction Using Long-acting Injectable Naltrexone, and Criminal Justice Drug Abuse Treatment Studies 2 (CJ DATS 2). Dr. Gordon’s prior funding includes Methadone Maintenance for Prisoners, funded by the National Institute on Drug Abuse, Injectable Naltrexone Treatment of Opioid-Dependent Parolees/Probationers, funded by the Dana Foundation and the University of Pennsylvania, and Evaluation of an Outpatient Substance Abuse Treatment Program for Adolescents, funded by the Center for Substance Abuse Treatment.

Dr. Gordon is a two-time recipient of the NIH Clinical Research Loan Repayment Program (2006-2008 and 2008-2009). Furthermore, he has been the recipient of three travel awards to attend conferences, two from the National Institute on Drug Abuse (2005 and 2006), and one from the College on Problems of Drug Dependence (2007). Dr. Gordon also received the FRI 2008 Daniel Mendelsohn/ New Investigator Award.

Researcher Profile Archive